HomeProductsBioactive CompoundsProtein Kinase TargetsBTKNemtabrutinib
Chemical structure of CAS 2095393-15-8

Nemtabrutinib

CAS No.2095393-15-8
MDL No.MFCD31692379
MFC25H23ClN4O4
MW478.90
InChI KeyJSFCZQSJQXFJDS-QAPCUYQASA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2095393-15-8
Product NameNemtabrutinib

Associated Conditions

neoplasm·lymphoid neoplasm·chronic lymphocytic leukemia·liver disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia.

Journal of hematology & oncology • Vol. 13, Issue 1 • 2020
PMID: 31992353PMC: PMC6988309DOI: 10.1186/s13045-019-0821-7

The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation.

Cancer discovery • Vol. 8, Issue 10 • 2018
PMID: 30093506PMC: PMC6261467DOI: 10.1158/2159-8290.CD-17-1409

Melatonin induced changes in gonads; pelage and thermogenic characters in the white-footed mouse, Peromyscus leucopus.

Comparative biochemistry and physiology. C: Comparative pharmacology • Vol. 53, Issue 2 • 1976
PMID: 5240DOI: 10.1016/0306-4492(76)90054-x

Documentation